Company / Book Value per Share
REGENXBIO Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.073
FY2025
5-year range
$2.073 / $12.052
FY2021-FY2025
Trend
-64.8%
vs FY2024
Sector context
#148 of 209
Health Care
What the data says
At $2.073, REGENXBIO Inc.'s book value per share ranks #148 of 209 in the Health Care sector. Book Value per Share has declined for 3 consecutive years, from $12.052 in FY2022 to $2.073 in FY2025.
Based on SEC 10-K filings.
$2.073 in FY2025 with a 5-year CAGR of -31.5%.
Declined from $7.2 to $2.073 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -44.4%
- 5-Year CAGR
- -31.5%
- 10-Year CAGR
- -
Sector benchmark
#148 of 209 in Health CareTop 71% of 209This company $2.073 Sector average $215.686
▼
-99.0% below sector average
Key checks
Key Insights
- REGENXBIO Inc.'s book value per share has declined for 3 consecutive years.
- 5-year CAGR of -31.5%, indicating a declining trend.
- In FY2025, book value per share decreased 64.8% year-over-year.
- Ranks #148 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.073 | -64.8% |
| FY2024 | $5.895 | -18.1% |
| FY2023 | $7.2 | -40.3% |
| FY2022 | $12.052 | +0.3% |
| FY2021 | $12.013 | -12.7% |
| FY2020 | $13.756 | +171.5% |
| FY2019 | $5.067 | -68.8% |
| FY2018 | $16.26 | +135.2% |
| FY2017 | $6.913 | +1094.5% |
| FY2016 | -$0.695 | +86.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026